Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Pfizer Inc. sell Snowman

Start price
€26.80
07.12.23 / 50%
Target price
-
07.12.24
Performance (%)
-1.67%
Price
€25.97
13:41
Summary
This prediction is currently active. With a performance of -1.67%, the SELL prediction for Pfizer Inc. by Snowman is down slightly. Dividends of €0.39 are taken into consideration when calculating the performance. This prediction currently runs until 07.12.24. The prediction end date can be changed by Snowman at any time. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Pfizer Inc. 9.635% 9.635%
iShares Core DAX® 0.000% -2.064%
iShares Nasdaq 100 0.626% -2.884%
iShares Nikkei 225® 1.568% -5.892%
iShares S&P 500 0.334% -2.281%

According to Snowman what are the pros and cons of Pfizer Inc. for the foreseeable future?

Pros
Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
Could be worthwhile Investment >10% per year
Undervalued
High dividend yield expected
Small Risks for its business
Differentiated customer and product portfolio
Known brand
Market Leader or Top 3
Cons

Comments by Snowman for this prediction

In the thread Pfizer Inc. diskutieren

Sell Pfizer Inc.

Stopped prediction by Snowman for Pfizer Inc.

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€49.74
20.07.22
€55.00
20.07.23
-33.55%
21.07.23

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€41.11
09.11.21
€60.00
09.11.22
14.73%
19.01.22

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.35
15.03.21
€50.00
15.03.22
43.43%
09.11.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.01
18.12.20
€34.00
18.12.21
-5.35%
15.03.21

Small challenges to pay loans and raise capital
Innovative
Very small cyclical dependencies
Some uniques